StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
China National Medicines Corporation Ltd.
Shanghai Stock Exchange:600511.SS
Sector
Location
Market Cap
USD 3.11 B
Share Price
USD 4.12
Avg Daily Volume
3,723,529
Change (1 day)
0.69%
Change (1 year)
-3.69%
Change (YTD)
-12.04%
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2024: USD 10.10 M
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses is USD 10.10 M for the year ending December 31, 2024, a 0.67% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.
-
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2023 was USD 10.03 M, a 3.29% change year over year.
-
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2022 was USD 9.71 M, a 10.65% change year over year.
-
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2021 was USD 8.77 M, a 10.41% change year over year.
-
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2020 was USD 7.95 M, a 23.17% change year over year.
Competitors
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
McKesson Corporation
USD 710.82
MCK
-4.75
-0.66%
Elevance Health Inc.
USD 336.21
ELV
-3.86
-1.14%
Cencora, Inc.
USD 294.65
COR
-2.41
-0.81%
BeOne Medicines Ltd.
USD 269.70
ONC
+17.56
6.96%
JD Health International Inc.
USD 5.89
6618.HK
+0.11
1.91%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.55
2607.HK
-0.01
-0.95%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.32
2196.HK
+0.14
6.59%
Sinopharm Group Co. Ltd.
USD 2.38
1099.HK
-0.01
-0.29%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.63
002653.SZ
+0.15
2.28%
Hikma Pharmaceuticals PLC
USD 26.64
HIK.L
+0.12
0.46%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.29
0874.HK
+0.01
0.26%
Galenica AG
USD 109.85
GALE.SW
-1.61
-1.44%
Option Care Health, Inc.
USD 30.74
OPCH
+0.06
0.20%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.01
600079.SS
+0.05
1.59%
China Resources Pharmaceutical Group Limited
USD 0.68
3320.HK
+0.01
1.17%
China Medical System Holdings Limited
USD 1.67
0867.HK
+0.00
0.18%
Kangmei Pharmaceutical Co., Ltd.
USD 0.29
600518.SS
-0.00
-0.06%
Amneal Pharmaceuticals, Inc.
USD 8.27
AMRX
-0.15
-1.78%
MediPal Holdings Corporation
USD 16.12
7459.T
-0.00
-0.03%
Key Data
| Date | Research and Development (R&D) Expenses | Revenue | Revenue | Gross Profit |
|---|
Competitors
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
McKesson Corporation
USD 710.82
MCK
-4.75
-0.66%
Elevance Health Inc.
USD 336.21
ELV
-3.86
-1.14%
Cencora, Inc.
USD 294.65
COR
-2.41
-0.81%
BeOne Medicines Ltd.
USD 269.70
ONC
+17.56
6.96%
JD Health International Inc.
USD 5.89
6618.HK
+0.11
1.91%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.55
2607.HK
-0.01
-0.95%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.32
2196.HK
+0.14
6.59%
Sinopharm Group Co. Ltd.
USD 2.38
1099.HK
-0.01
-0.29%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.63
002653.SZ
+0.15
2.28%
Hikma Pharmaceuticals PLC
USD 26.64
HIK.L
+0.12
0.46%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.29
0874.HK
+0.01
0.26%
Galenica AG
USD 109.85
GALE.SW
-1.61
-1.44%
Option Care Health, Inc.
USD 30.74
OPCH
+0.06
0.20%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.01
600079.SS
+0.05
1.59%
China Resources Pharmaceutical Group Limited
USD 0.68
3320.HK
+0.01
1.17%
China Medical System Holdings Limited
USD 1.67
0867.HK
+0.00
0.18%
Kangmei Pharmaceutical Co., Ltd.
USD 0.29
600518.SS
-0.00
-0.06%
Amneal Pharmaceuticals, Inc.
USD 8.27
AMRX
-0.15
-1.78%
MediPal Holdings Corporation
USD 16.12
7459.T
-0.00
-0.03%